Suprelorin

RSS

Authorised

This medicine is authorised for use in the European Union

deslorelin acetate
MedicineVeterinaryAuthorised

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

български (BG) (93.36 KB - PDF)

Visualizza

español (ES) (81.97 KB - PDF)

Visualizza

čeština (CS) (93.99 KB - PDF)

Visualizza

dansk (DA) (83.34 KB - PDF)

Visualizza

Deutsch (DE) (82.76 KB - PDF)

Visualizza

eesti (ET) (82.18 KB - PDF)

Visualizza

ελληνικά (EL) (93.76 KB - PDF)

Visualizza

français (FR) (82.44 KB - PDF)

Visualizza

Gaeilge (GA) (83.57 KB - PDF)

Visualizza

hrvatski (HR) (92.27 KB - PDF)

Visualizza

italiano (IT) (82.29 KB - PDF)

Visualizza

latviešu (LV) (94.29 KB - PDF)

Visualizza

lietuvių (LT) (94.03 KB - PDF)

Visualizza

magyar (HU) (94.15 KB - PDF)

Visualizza

Malti (MT) (95.95 KB - PDF)

Visualizza

Nederlands (NL) (82.05 KB - PDF)

Visualizza

polski (PL) (95.62 KB - PDF)

Visualizza

português (PT) (83.01 KB - PDF)

Visualizza

română (RO) (94.17 KB - PDF)

Visualizza

slovenčina (SK) (94.08 KB - PDF)

Visualizza

slovenščina (SL) (82.27 KB - PDF)

Visualizza

suomi (FI) (81.54 KB - PDF)

Visualizza

svenska (SV) (82.05 KB - PDF)

Visualizza

Íslenska (IS) (83.29 KB - PDF)

Visualizza

norsk (NO) (82 KB - PDF)

Visualizza

Product information

български (BG) (91.78 KB - PDF)

Visualizza

español (ES) (81.51 KB - PDF)

Visualizza

čeština (CS) (92.48 KB - PDF)

Visualizza

dansk (DA) (82.05 KB - PDF)

Visualizza

Deutsch (DE) (81.72 KB - PDF)

Visualizza

eesti (ET) (81.22 KB - PDF)

Visualizza

ελληνικά (EL) (91.79 KB - PDF)

Visualizza

français (FR) (81.63 KB - PDF)

Visualizza

Gaeilge (GA) (81.36 KB - PDF)

Visualizza

hrvatski (HR) (91.56 KB - PDF)

Visualizza

italiano (IT) (81.76 KB - PDF)

Visualizza

latviešu (LV) (92.14 KB - PDF)

Visualizza

lietuvių (LT) (92.19 KB - PDF)

Visualizza

magyar (HU) (92.76 KB - PDF)

Visualizza

Malti (MT) (93.86 KB - PDF)

Visualizza

Nederlands (NL) (81.15 KB - PDF)

Visualizza

polski (PL) (93.22 KB - PDF)

Visualizza

português (PT) (82.53 KB - PDF)

Visualizza

română (RO) (91.73 KB - PDF)

Visualizza

slovenčina (SK) (81.75 KB - PDF)

Visualizza

slovenščina (SL) (81.76 KB - PDF)

Visualizza

suomi (FI) (81.11 KB - PDF)

Visualizza

svenska (SV) (81.47 KB - PDF)

Visualizza

Íslenska (IS) (81.52 KB - PDF)

Visualizza

norsk (NO) (81.52 KB - PDF)

Visualizza

български (BG) (93.36 KB - PDF)

Visualizza

español (ES) (81.97 KB - PDF)

Visualizza

čeština (CS) (93.99 KB - PDF)

Visualizza

dansk (DA) (83.34 KB - PDF)

Visualizza

Deutsch (DE) (82.76 KB - PDF)

Visualizza

eesti (ET) (82.18 KB - PDF)

Visualizza

ελληνικά (EL) (93.76 KB - PDF)

Visualizza

français (FR) (82.44 KB - PDF)

Visualizza

Gaeilge (GA) (83.57 KB - PDF)

Visualizza

hrvatski (HR) (92.27 KB - PDF)

Visualizza

italiano (IT) (82.29 KB - PDF)

Visualizza

latviešu (LV) (94.29 KB - PDF)

Visualizza

lietuvių (LT) (94.03 KB - PDF)

Visualizza

magyar (HU) (94.15 KB - PDF)

Visualizza

Malti (MT) (95.95 KB - PDF)

Visualizza

Nederlands (NL) (82.05 KB - PDF)

Visualizza

polski (PL) (95.62 KB - PDF)

Visualizza

português (PT) (83.01 KB - PDF)

Visualizza

română (RO) (94.17 KB - PDF)

Visualizza

slovenčina (SK) (94.08 KB - PDF)

Visualizza

slovenščina (SL) (82.27 KB - PDF)

Visualizza

suomi (FI) (81.54 KB - PDF)

Visualizza

svenska (SV) (82.05 KB - PDF)

Visualizza

Íslenska (IS) (83.29 KB - PDF)

Visualizza

norsk (NO) (82 KB - PDF)

Visualizza

Product details

Name of medicine
Suprelorin
Active substance
deslorelin acetate
International non-proprietary name (INN) or common name
deslorelin acetate

Pharmacotherapeutic group

Pituitary and hypothalamic hormones and analogues

Authorisation details

EMA product number
EMEA/V/C/000109

Assessment history

This page was last updated on

Share this page